8-K: Select Medical Holdings Reports Mixed Q2 Results, Declares Dividend and Completes Concentra IPO

Select Medical Holdings Corporation announced its second quarter 2024 financial results, including a revenue increase of 5.1%, alongside the declaration of a $0.125 per share cash dividend and the completion of Concentra's IPO.

Summary

• Select Medical's revenue for the second quarter of 2024 increased by 5.1% to $1,759.7 million, compared to $1,674.5 million in the same quarter of the previous year.
• Net income for the quarter rose by 3.2% to $94.8 million, up from $91.9 million year-over-year.
• Adjusted EBITDA for the quarter increased by 3.1% to $226.3 million, compared to $219.5 million in the prior year.
• Earnings per common share were $0.60 for the quarter, slightly down from $0.61 in the same quarter last year.
• For the first six months of 2024, revenue increased by 6.3% to $3,548.5 million, and net income increased by 19.7% to $211.9 million.
• The company declared a cash dividend of $0.125 per share, payable on or about August 30, 2024, to shareholders of record on August 14, 2024.
• Concentra, a subsidiary of Select Medical, completed an IPO of 22,500,000 shares at $23.50 per share, raising gross proceeds of $528.8 million.
• Select Medical reaffirmed its 2024 business outlook, expecting revenue between $6.9 billion and $7.1 billion and adjusted EBITDA between $845 million and $885 million.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to revenue growth, the successful Concentra IPO, and the dividend declaration. However, some margin pressures and a slight decrease in EPS temper the overall positive outlook.

Positives

• Revenue increased across all segments for both the quarter and the first six months of 2024.
• Net income and adjusted EBITDA showed growth for both the quarter and the first six months of 2024.
• The company declared a cash dividend of $0.125 per share.
• The successful IPO of Concentra generated significant capital.
• The company reaffirmed its positive business outlook for 2024.
• The rehabilitation hospital segment showed strong growth in both revenue and adjusted EBITDA.
• The critical illness recovery hospital segment showed strong growth in both revenue and adjusted EBITDA.

Negatives

• Earnings per common share for the second quarter decreased slightly from $0.61 to $0.60.
• The outpatient rehabilitation segment experienced a decrease in adjusted EBITDA for both the quarter and the first six months of 2024.
• The Concentra segment experienced a slight decrease in adjusted EBITDA margin for both the quarter and the first six months of 2024.
• The occupancy rate for critical illness recovery hospitals decreased slightly from 68% to 67% for the second quarter.

Risks

• Changes in government reimbursement policies could reduce revenue and profitability.
• Adverse economic conditions, including inflation, could increase labor and operating costs.
• Shortages of qualified healthcare professionals could limit the company's ability to staff facilities.
• Public health threats, such as pandemics, could negatively impact patient volumes and revenues.
• Failure to maintain Medicare certifications could cause revenue and profitability to decline.
• Competition may limit the company's ability to grow and could decrease revenue and profitability.
• Security breaches of information technology systems could lead to legal and reputational harm.

Future Outlook

Select Medical reaffirmed its 2024 business outlook, expecting revenue between $6.9 billion and $7.1 billion, adjusted EBITDA between $845 million and $885 million, fully diluted earnings per share between $1.95 and $2.19, and adjusted earnings per share between $1.96 and $2.20.

Management Comments

• Select Medical is reaffirming its 2024 business outlook, which was provided most recently in its May 2, 2024, press release.
• The declaration and payment of dividends in the future are at the discretion of Select Medicals Board of Directors after taking into account various factors.

Industry Context

The healthcare industry is facing challenges such as changing reimbursement policies, rising costs, and labor shortages. Select Medical's results reflect these industry-wide trends, with revenue growth offset by some margin pressures in certain segments. The successful IPO of Concentra is a strategic move to unlock value and potentially improve the company's financial position.

Comparison to Industry Standards

• Select Medical's revenue growth of 5.1% in Q2 is comparable to other large healthcare providers, but the slight decrease in EPS and margin pressures in some segments may be a concern.
• HCA Healthcare, a major hospital operator, reported a 6.1% increase in revenue in their most recent quarter, showing similar growth trends.
• Universal Health Services, another competitor, reported a 7.1% increase in revenue, indicating that Select Medical's growth is slightly below some of its peers.
• The adjusted EBITDA margin of 23.1% in the rehabilitation hospital segment is strong compared to industry averages, while the outpatient rehabilitation segment's 9.1% margin is below average.
• The Concentra IPO is a significant event, similar to other healthcare companies spinning off divisions to focus on core operations and unlock shareholder value.

Stakeholder Impact

• Shareholders will benefit from the declared cash dividend and the potential for increased value from the Concentra IPO.
• Employees may be impacted by the company's efforts to manage labor costs and address staffing shortages.
• Customers will continue to receive healthcare services from Select Medical's various facilities.
• Suppliers and creditors will be impacted by the company's financial performance and capital structure.

Next Steps

• Select Medical will host a conference call on August 2, 2024, to discuss the second quarter results and business outlook.
• The company will continue to execute its stock repurchase program, which is authorized until December 31, 2025.
• Select Medical will monitor the performance of its various segments and adjust strategies as needed.

Key Dates

Keywords

Select Medical, Healthcare, Financial Results, Dividend, IPO, Concentra, Rehabilitation, Critical Illness Recovery, Outpatient Services, EBITDA